In my last post, I wrote about the change made in January by the Food & Drug Administration (FDA) to its rules regarding the dispensing of Mifepristone, the chemical abortion drug, and the intentions of Walgreens and CVS to distribute it. I am writing today with an update of that article. 21 States said “No!”…
We’ve talked in earlier articles about the Socially Responsible Investment Guidelines of the United States Conference of Catholic Bishops (USCCB). In that 26-page document, the bishops enumerate a number of business activities that make a company unfit for investment. The investment activities that the USCCB identify as unfit for investment include, but are not limited…
I began transforming into a Catholic investor while working as a portfolio manager for Northwestern Mutual Life. I had been a pro-life Catholic for a long time and was serving on the Wisconsin Right to Life Board of Directors. A stockbroker I worked with regularly approached me with a new idea for a stock to…
